Simplicity Solutions’s Novavax NVAX Stock Holding History

Simplicity Solutions’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-4,891	Closed	-$545K	–	809
2020 Q4	$545K	Buy	+4,891	New	+$520K	0.01%	677

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Simplicity Solutions's NVAX Position: Q1 2021 in Review

Simplicity Solutions sold out of Novavax (NVAX) in Q1 2021, closing a stake of 4,891 shares — an estimated $545K sold.

Simplicity Solutions first reported a position in NVAX in Q4 2020 and held it in 1 quarter. The position peaked at $545K in Q4 2020. 389 funds tracked by Wall St. Rank hold NVAX as of Q1 2021.

Simplicity Solutions reported no remaining Novavax position as of Q1 2021 after selling out during the quarter.
Simplicity Solutions sold 4,891 Novavax shares in Q1 2021, an estimated $545K.
Simplicity Solutions first reported a position in Novavax in Q4 2020 and held it in 1 quarter.
Simplicity Solutions's Novavax position peaked at $545K in Q4 2020.
389 funds tracked by Wall St. Rank held Novavax as of Q1 2021.

Based on Simplicity Solutions's 13F filing for Q1 2021, filed 13 May 2021.